Rights and permissions
About this article
Cite this article
Cost effectiveness of misoprostol prophylaxis in elderly is equivocal. Pharmacoecon. Outcomes News 48, 2 (1996). https://doi.org/10.1007/BF03309938
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03309938